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SHORT COMMUNICATION

Coronary Artery Bypass Grafting After Percutaneous
Coronary Intervention

Syed Shahabuddin1, Shahid Ahmed Sami1, Junaid Alam Ansari2, Shazia Perveen1, Shumaila Furnaz1,
Saulat Fatimi1 and Hasanat Sharif1

ABSTRACT
Following percutaneous intervention (PCI), restenosis, progression of disease and multi-vessel involvement may require
further intervention in the form of surgical revascularization. Patients with coronary artery bypass grafting (CABG) done
after PCI were evaluated to find out the reason for the need of surgical revascularization. Over a period of 12 months, 610
patients underwent CABG. Out of them, 34 patients had previous PCI/stenting. Coronary risk factors including
hypertension in 85%, diabetes mellitus in 60%, dyslipidemia in 60%, tobacco use in 50% and a positive family history was
present in 53% of the patients. All patients were symptomatic. Multi-vessel disease was present in 67% and single vessel
in 4.7%. The extent of disease and stenosis of stents were responsible for reintervention. Careful selection of patients is
required in presence of multiple risk factors for coronary artery disease to provide maximum benefit by either PCI or CABG.
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Cardiovascular disease including coronary artery
disease are a leading cause of death worldwide.
Coronary artery disease (CAD) is treated either with medical
therapy, interventional therapy including percutaneous
coronary intervention (PCI) or surgical revascularization
in the form of coronary artery bypass grafting (CABG).
The widespread popularity and use of percutaneous
intervention (PCI) for coronary revascularization has
brought substantial change in the patient population
referred for surgical revasculari-zation.1
However, after PCI, further interventions or surgery is
required for restenosis, progression of disease and
multivessel involvement. In this study, the patients with
CABG done after PCI were evaluated to find out the
reason for the need of surgical revascularization.
From January to December 2006, 610 patients underwent CABG. This cohort included all patients whether
the revascularization was on pump, off-pump or re-do
CABG. Out of them, 34 patients had previous successful
or attempted PCI. Drug-eluting stent were replacing
the previous methods of PCI. These patients were
eventually referred for surgical revascularization.
Indication of surgical revascularization was on the basis
of clinical and angiographic findings in terms of
restenosis of stent or stented vessel, extension and
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advancement of primary disease with or without stent
involvement and the failed angioplasty.
Standard operating strategy was utilized. Cardiopulmonary bypass was established using right atrial
and aortic cannulation after systemic heparinization.
Myocardial protection was done with blood cardioplegia
into aortic root along with moderate systemic hypothermia (28 - 32°C) and topical cooling. Distal coronary
anastomoses were performed on still heart. Proximal
end of the vein graft was anastomosed to aorta under
partial occluding clamp. Subsequently, the heart was
allowed to perfuse and weaned from CPB. Protamine
was given to neutralize heparin. Chest closure was done
after hemostasis and placement of drains and pacing
wires.
In off-pump cases, Genzyme stabilizer was utilized to
facilitate construction of distal coronary anastomosis
after positioning the heart with the help of either
pericardial sutures or warm swab behind the heart.
Intraoperative variables were studied and outcome in
terms of mortality and morbidity assessed.
There was no mortality. A total of 34 patients underwent
coronary artery bypass grafting after initial PCI. Out of
them, 33 were males and one was female. Their median
age was 53.5 years, ranged from 40 to 72 years. Half of
the patients were tobacco addicted. Among risk factors,
hypertension was the mostly found factors with 85.3%.
They were all symptomatic.
Disease profile shows 67.6% had multi-vessel disease
while 14.7% had single vessel disease. Two patients
were operated after failure of PCI. Fourteen patients
were having progression of the disease with patent stent
and other 14 patients had stenosis of their stent. Rest of
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the 4 patients had both progressions of the disease in
the native coronaries as well as stent disease. The
distribution of PCI and its type along with the reason for
surgical revascularization is given in Table I. The median
time from PCI to CABG was 3 years. Amongst all,
Internal Mammary Artery (IMA) was predominantly used
(94.1%), with an average of 3 grafts per patient.
Postoperatively 2 patients developed atrial fibrillation
and one patient required reopening for bleeding.

towards poorer outcome when compared to first time
CABG. Therefore, to begin with optimal medical therapy
for stable CAD is entirely acceptable and reasonable.
The PCI stands as a valid option for acute coronary
syndrome and refractory angina with discrete coronary
lesion without multi-vessel involvement. The surgical
revascularization has remained long lasting and superior
to medical treatment and PCI. Even in large clinical trials
patients do cross-over to surgical revascularization
reinforcing that the CABG is complimentary to other
forms of treatment.

Table I: Identified reasons for revascularization (n=34).
Total

Blocked

Extended Blocked/
extended

Failed

No
contact

The limitations of the study are that it was a retrospective review, having small sample and single centre
study over a period of one year. Despite showing the
reasons for CABG after PCI its results cannot be
generalized. However, it will be useful for the awareness
of our medical community and to guide patient in the
right direction.

Type of stents
DES

19

6

11

2

-

-

Non DES

7

4

2

1

-

-

Rotablade

1

1

-

-

-

-

Balloon

2

-

1

1

-

-

Failed

2

-

-

-

2

No contact

3

-

-

-

34

11

14

4

Total

3

2

Percutaneous interventions are successful method of
revascularization and delays surgery, but future
reinterventions are common and both extent of disease
and stenosis of stents are responsible for reintervention.
This needs careful selection of patients especially in
presence of multiple risk factors for coronary artery
disease to provide maximum benefit.

3

It has been shown that PCI did not reduce the risk of
death in cases of myocardial infarction when added to
optimal medical therapy.2 This large study supports
recommendation of optimal medical therapy to begin
with in patients with stable CAD. PCI has established
role in patients presenting with acute coronary
syndrome.3 CABG compared to medical treatment or
PCI remains superior in terms of repeat revascularization and long-term relief of angina.4
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